Mantle Cell Lymphoma — Trials

Mantle Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 180
Recruiting: 93
Ph III recruiting: 6
Growth YoY: —
Industry share: 26%
Top sponsor: City of Hope Medical Center
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (121)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07784101	A Phase 3 Study to Compare the Efficacy of ICP-248 in Combination With Orelabrutinib Versus Pirtobrutinib in Participants With Relapsed or Refractory Mantle Cell Lymphoma (r/r MCL).	not yet recruiting	Phase 3	280	Beijing InnoCare Pharma Tech Co., Ltd.INDUSTRY	1	Aug 25, 2026	clinicaltrials

Data updated 23 days agoSource updated Aug 25, 2026source: clinicaltrials